| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Clinical implications of fibroblast activation protein in patients with colon cancer.
|
Clin Cancer Res
|
2007
|
1.80
|
|
2
|
Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients.
|
Int J Cancer
|
2010
|
1.31
|
|
3
|
Regulation of fibroblast migration on collagenous matrix by a cell surface peptidase complex.
|
J Biol Chem
|
2002
|
1.31
|
|
4
|
Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer.
|
Cancer Lett
|
2009
|
1.30
|
|
5
|
Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer.
|
Gynecol Oncol
|
2008
|
1.27
|
|
6
|
The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices.
|
Cancer Res
|
2006
|
1.15
|
|
7
|
Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer.
|
Int J Cancer
|
2014
|
1.00
|
|
8
|
The expression of a type II transmembrane serine protease (Seprase) in human gastric carcinoma.
|
Oncology
|
2004
|
0.96
|
|
9
|
Seprase, a membrane-type serine protease, has different expression patterns in intestinal- and diffuse-type gastric cancer.
|
Oncology
|
2003
|
0.96
|
|
10
|
Molecular proximity of seprase and the urokinase-type plasminogen activator receptor on malignant melanoma cell membranes: dependence on beta1 integrins and the cytoskeleton.
|
Carcinogenesis
|
2002
|
0.95
|
|
11
|
Plasma seprase and DPP4 levels as markers of disease and prognosis in cancer.
|
Dis Markers
|
2012
|
0.91
|
|
12
|
Activation of EDTA-resistant gelatinases in malignant human tumors.
|
Cancer Res
|
2006
|
0.88
|
|
13
|
'Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer'.
|
Cancer Lett
|
2005
|
0.87
|
|
14
|
Induction of Smad1 by MT1-MMP contributes to tumor growth.
|
Int J Cancer
|
2007
|
0.86
|
|
15
|
Elevation of seprase expression and promotion of an invasive phenotype by collagenous matrices in ovarian tumor cells.
|
Int J Cancer
|
2009
|
0.85
|
|
16
|
A conserved sequence within the propeptide domain of membrane type 1 matrix metalloproteinase is critical for function as an intramolecular chaperone.
|
J Biol Chem
|
2001
|
0.80
|
|
17
|
Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China.
|
Oncology
|
2008
|
0.78
|
|
18
|
Tumor progression and metastasis from genetic to microenvironmental determinants: a workshop of the tumor progression and metastasis NIH study section in honor of Dr. Martin L. Padarathsingh, May 31, 2006, Georgetown, Washington, DC.
|
Cancer Biol Ther
|
2006
|
0.76
|
|
19
|
Type-II transmembrane prolyl dipeptidases and matrix metalloproteinases in membrane vesicles of active endothelial cells.
|
Adv Exp Med Biol
|
2006
|
0.75
|